– First ever on-chain options protocol to receive Arbitrum Foundation Grant prior to full launch – Moby set to drive next narrative for DeFi with its unique SLE (Synchronized Liquidity Engine) SINGAPORE, Jan. 23,… Read More »Moby, the Next On-chain Options Protocol, Receives Grant from Arbitrum Foundation
Crexendo® enables service providers to assume full customer ownership and control of their commercial model and operate at larger profit margins than most competitor solutions. SAN ANTONIO, Jan. 23, 2024 /PRNewswire/ — Frost & Sullivan recently… Read More »Crexendo® Earns Frost & Sullivan’s 2024 Competitive Strategy Leadership Award for Excellence in Cloud Communications
BEIJING, Jan. 23, 2024 /PRNewswire/ — Datasea Inc., (NASDAQ: DTSS) (“Datasea” or the “Company”), a Nevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology… Read More »Datasea Pre-Announces First Half 2024 Revenue of $18.2 Million, a 1,037.5% Year-Over-Year Increase
BEIJING, Jan. 23, 2024 /PRNewswire/ — The white tern, with black eyes and a black, sharp bill, is a scarce migrant seabird that is completely white. Although widespread around the Pacific, white terns breed… Read More »China Matters’ Feature: Birding Pals’s Project X in Zhongshan
Dukosi is a pioneering developer of cell monitoring and battery management technology, offering cutting-edge solutions for real-time monitoring and accurate data analysis SAN ANTONIO, Jan. 23, 2024 /PRNewswire/ — Frost & Sullivan recently researched the battery… Read More »Dukosi Ltd. Recognized with Frost & Sullivan’s 2023 Global Market Leadership Award for Revolutionizing the Battery Cell Monitoring Industry
Collaboration aims to transform research to improve patient outcomes and enhance the understanding of ALS and motor neuron diseases (MND) MORRISVILLE, N.C., Jan. 23, 2024 /PRNewswire/ — Metabolon, Inc., the global leader in providing… Read More »Metabolon and Sheffield Institute for Translational Neuroscience Join Forces to Propel ALS Research and Biomarker Discovery